https://portal.novartis.com.br/cardiologia/insuficiencia-cardiaca/alem-dos-sintomas-biomarcadores-na-avaliacao-e-manejo-da-insuficiencia-cardiaca/2024-08-09T14:41:33-03:00https://portal.novartis.com.br/cardiologia/mmc_699/insuficiencia-cardiaca/o-papel-da-educacao-do-paciente-na-adesao-medicamentosa-e-controle-da-insuficiencia-cardiaca/2025-05-23T13:46:34-03:00https://portal.novartis.com.br/cardiologia/mmc_699/insuficiencia-cardiaca/importancia-da-rapida-otimizacao-do-tratamento-da-insuficiencia-cardiaca-orientado-por-diretrizes/2024-09-24T16:54:34-03:00https://portal.novartis.com.br/cardiologia/mmc_699/insuficiencia-cardiaca/desafios-e-estrategias-no-diagnostico-da-insuficiencia-cardiaca-com-fracao-de-ejecao-preservada-no-brasil/2024-10-16T09:30:48-03:00https://portal.novartis.com.br/cardiologia/mmc_925/dislipidemia-arterosclerose/pilulas-de-conteudo-com-o-dr-jose-rocha-faria-neto/2024-11-11T10:56:45-03:00https://portal.novartis.com.br/cardiologia/mmc_925/dislipidemia-arterosclerose/estudo-orion-10-inclisirana-em-pacientes-com-ldl-colesterol-elevado/2024-11-25T16:46:39-03:00https://portal.novartis.com.br/cardiologia/sybrava/dislipidemia-arterosclerose/video-guia-mostra-como-aplicar-sybrava-a-medicos-habilitados/2024-11-19T11:06:22-03:00https://portal.novartis.com.br/cardiologia/mmc_925/dislipidemia-arterosclerose/estudo-orion-9-inclisirana-para-o-tratamento-da-hipercolesterolemia-familiar-heterozigotica-hfhe/2024-11-25T09:48:55-03:00https://portal.novartis.com.br/cardiologia/mmc_925/dislipidemia-arterosclerose/estudo-orion-11-inclisirana-em-pacientes-com-doenca-cardiovascular-aterosclerotica-dcva-ou-um-risco-equivalente-de-dcva/2024-11-25T16:47:19-03:00https://portal.novartis.com.br/cardiologia/mmc_925/dislipidemia-arterosclerose/inclisirana-no-estudo-victorion-initiate/2025-04-03T17:51:33-03:00https://portal.novartis.com.br/cardiologia/mmc_925/dislipidemia-arterosclerose/sybrava-inclisirana-reducao-do-ldl-c-em-pacientes-pos-infarto-agudo-do-miocardio-iam/2025-07-30T11:37:26-03:00https://portal.novartis.com.br/cardiologia/mmc_925/dislipidemia-arterosclerose/inclisirana-no-manejo-de-pacientes-com-historico-de-ldl-c-elevado-e-iam/2025-02-04T08:48:24-03:00https://portal.novartis.com.br/cardiologia/mmc_925/dislipidemia-arterosclerose/estudo-orion-8-eficacia-e-seguranca-de-longo-prazo-da-inclisirana/2025-08-11T11:42:16-03:00https://portal.novartis.com.br/cardiologia/sybrava/dislipidemia-arterosclerose/o-que-e-sybrava/2025-08-07T13:49:28-03:00https://portal.novartis.com.br/cardiologia/sybrava/dislipidemia-arterosclerose/mecanismo-de-acao-de-sybrava/2025-08-07T13:50:09-03:00https://portal.novartis.com.br/cardiologia/sybrava/dislipidemia-arterosclerose/sybrava-inclisirana-na-pratica-clinica/2025-08-07T13:50:53-03:00https://portal.novartis.com.br/cardiologia/sybrava/dislipidemia-arterosclerose/evidencias-de-sybrava-inclisirana/2025-08-07T13:52:42-03:00https://portal.novartis.com.br/cardiologia/mmc_925/dislipidemia-arterosclerose/o-desafio-da-intolerancia-as-estatinas/2025-11-10T09:47:44-03:00